Health
Roche Romania’s Expectations For 2015
Roche Romania, the largest player on the local pharmaceutical market, estimates the industry will register tepid growth, of 2-3%, in 2015.
Antibiotice Feels The Pinch Of Falling Prices And Russian Crisis
Romanian state-run drug maker Antibiotice Iasi says its exports, weighing 30% in revenue, felt the fallout of declining prices internationally, as well as of the crisis in Russia and Ukraine...
Sanador Set To Open New Clinic, Reach 1,300 Employees And Increase Revenue By 10% In 2015
Romanian private healthcare company Sanador will open a large clinic next year, the first major expansion step it takes after the opening, in 2011, of the Bucharest hospital, while its reven...
Euromedic Romania Set To Speed Up Revenue Growth In 2015
Euromedic Romania, the company that manages ten medical imaging centers countrywide, expects revenue to rise by 3.5% this year, from 49.5 million lei (EUR11 million) in 2013.
Polisano Targets 54% Healthcare Revenue Growth To RON100M In 2015
Polisano group, the only integrated entrepreneurial business in the Romanian healthcare industry, is likely to generate healthcare revenue worth RON100 million in 2015, up 54% from 2014, whe...
Ponderas Hospital Heads Toward RON50M In Revenue
Ponderas Hospital, specialized in weight loss surgery, expects revenue worth around 40 million lei (EUR9 million) this year, up 25% on the year.
2014 In Review: Ten Most Important Events In Healthcare
The healthcare sector, which gets 27 billion lei (EUR6 billion) from the government and generates more than RON4.5 billion revenue per year for private companies, saw the Europharm plant in...
Novartis Set To Create New Jobs In Romania In 2015
In 2014, Swiss group Novartis registered a “modest” revenue increase in Romania amid a challenging year in the healthcare industry, estimates Elena Mitova, general manager of Novartis Pharma...
Cegedim Revises Pharma Market Forecast Considering “Harsher Cold Season”
Market research company Cegedim Romania changed its outlook about the trend of the drug market in 2014, from a negative one to one of slight growth.